353 related articles for article (PubMed ID: 16626752)
1. Effects of donepezil on memory and cognition in multiple sclerosis.
Christodoulou C; Melville P; Scherl WF; Macallister WS; Elkins LE; Krupp LB
J Neurol Sci; 2006 Jun; 245(1-2):127-36. PubMed ID: 16626752
[TBL] [Abstract][Full Text] [Related]
2. Donepezil improved memory in multiple sclerosis in a randomized clinical trial.
Krupp LB; Christodoulou C; Melville P; Scherl WF; MacAllister WS; Elkins LE
Neurology; 2004 Nov; 63(9):1579-85. PubMed ID: 15534239
[TBL] [Abstract][Full Text] [Related]
3. Donepezil for cognitive decline following coronary artery bypass surgery: a pilot randomized controlled trial.
Doraiswamy PM; Babyak MA; Hennig T; Trivedi R; White WD; Mathew JP; Newman MF; Blumenthal JA
Psychopharmacol Bull; 2007; 40(2):54-62. PubMed ID: 17514186
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial.
Feldman H; Gauthier S; Hecker J; Vellas B; Xu Y; Ieni JR; Schwam EM;
Int J Geriatr Psychiatry; 2005 Jun; 20(6):559-69. PubMed ID: 15920715
[TBL] [Abstract][Full Text] [Related]
5. Randomized placebo-controlled trial of donepezil in cognitive impairment in Parkinson's disease.
Leroi I; Brandt J; Reich SG; Lyketsos CG; Grill S; Thompson R; Marsh L
Int J Geriatr Psychiatry; 2004 Jan; 19(1):1-8. PubMed ID: 14716693
[TBL] [Abstract][Full Text] [Related]
6. Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial.
Doody RS; Ferris SH; Salloway S; Sun Y; Goldman R; Watkins WE; Xu Y; Murthy AK
Neurology; 2009 May; 72(18):1555-61. PubMed ID: 19176895
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic and prophylactic utility of the memory-enhancing drug donepezil hydrochloride on cognition of patients undergoing electroconvulsive therapy: a randomized controlled trial.
Prakash J; Kotwal A; Prabhu H
J ECT; 2006 Sep; 22(3):163-8. PubMed ID: 16957530
[TBL] [Abstract][Full Text] [Related]
8. Cognitive, global, and functional benefits of donepezil in Alzheimer's disease and vascular dementia: results from large-scale clinical trials.
Passmore AP; Bayer AJ; Steinhagen-Thiessen E
J Neurol Sci; 2005 Mar; 229-230():141-6. PubMed ID: 15760632
[TBL] [Abstract][Full Text] [Related]
9. A 12-week, double-blind, placebo-controlled trial of donepezil adjunctive treatment to risperidone in chronic and stable schizophrenia.
Akhondzadeh S; Gerami M; Noroozian M; Karamghadiri N; Ghoreishi A; Abbasi SH; Rezazadeh SA
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1810-5. PubMed ID: 18727948
[TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind, placebo-controlled trial of donepezil to improve memory in epilepsy.
Hamberger MJ; Palmese CA; Scarmeas N; Weintraub D; Choi H; Hirsch LJ
Epilepsia; 2007 Jul; 48(7):1283-91. PubMed ID: 17484756
[TBL] [Abstract][Full Text] [Related]
11. Donepezil treatment of severe Alzheimer's disease in nursing home settings. A responder analysis.
Jelic V; Haglund A; Kowalski J; Langworth S; Winblad B
Dement Geriatr Cogn Disord; 2008; 26(5):458-66. PubMed ID: 18984956
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of donepezil in early-stage Alzheimer disease: a randomized placebo-controlled trial.
Seltzer B; Zolnouni P; Nunez M; Goldman R; Kumar D; Ieni J; Richardson S;
Arch Neurol; 2004 Dec; 61(12):1852-6. PubMed ID: 15596605
[TBL] [Abstract][Full Text] [Related]
13. Effects of donepezil on verbal memory after semantic processing in healthy older adults.
FitzGerald DB; Crucian GP; Mielke JB; Shenal BV; Burks D; Womack KB; Ghacibeh G; Drago V; Foster PS; Valenstein E; Heilman KM
Cogn Behav Neurol; 2008 Jun; 21(2):57-64. PubMed ID: 18541979
[TBL] [Abstract][Full Text] [Related]
14. A 12-week, double-blind, placebo-controlled trial of donepezil as an adjunct to haloperidol for treating cognitive impairments in patients with chronic schizophrenia.
Lee BJ; Lee JG; Kim YH
J Psychopharmacol; 2007 Jun; 21(4):421-7. PubMed ID: 17092979
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of donepezil over 3 years: an open-label, multicentre study in patients with Alzheimer's disease.
Burns A; Gauthier S; Perdomo C
Int J Geriatr Psychiatry; 2007 Aug; 22(8):806-12. PubMed ID: 17199235
[TBL] [Abstract][Full Text] [Related]
16. Acute cognitive effects of donepezil in young, healthy volunteers.
Zaninotto AL; Bueno OF; Pradella-Hallinan M; Tufik S; Rusted J; Stough C; Pompéia S
Hum Psychopharmacol; 2009 Aug; 24(6):453-64. PubMed ID: 19637397
[TBL] [Abstract][Full Text] [Related]
17. Donepezil provides greater benefits in mild compared to moderate Alzheimer's disease: implications for early diagnosis and treatment.
Molinuevo JL; Berthier ML; Rami L
Arch Gerontol Geriatr; 2011; 52(1):18-22. PubMed ID: 19948364
[TBL] [Abstract][Full Text] [Related]
18. Neuropsychological test performance in healthy volunteers before and after donepezil administration.
Beglinger LJ; Gaydos BL; Kareken DA; Tangphao-Daniels O; Siemers ER; Mohs RC
J Psychopharmacol; 2004 Mar; 18(1):102-8. PubMed ID: 15107192
[TBL] [Abstract][Full Text] [Related]
19. A randomized, double-blind, placebo-controlled trial of donepezil hydrochloride (Aricept) for reducing the incidence of postoperative delirium after elective total hip replacement.
Sampson EL; Raven PR; Ndhlovu PN; Vallance A; Garlick N; Watts J; Blanchard MR; Bruce A; Blizard R; Ritchie CW
Int J Geriatr Psychiatry; 2007 Apr; 22(4):343-9. PubMed ID: 17006875
[TBL] [Abstract][Full Text] [Related]
20. Unemployment in multiple sclerosis: the contribution of personality and disease.
Strober LB; Christodoulou C; Benedict RH; Westervelt HJ; Melville P; Scherl WF; Weinstock-Guttman B; Rizvi S; Goodman AD; Krupp LB
Mult Scler; 2012 May; 18(5):647-53. PubMed ID: 22183935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
